Doxorubicin Hydrochloride Liposome Combined With Irinotecan Versus VIT Regimen in the Treatment of Pediatric Rhabdomyosarcoma

Condition:   Rhabdomyosarcoma, Child Interventions:   Drug: Doxorubicin Hydrochloride Liposome+Irinotecan;   Drug: Temozolomide+Irinotecan+Vincristine Sponsors:   Sun Yat-sen University;   CSPC Ouyi Pharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials